Blank Bio Raises $7.2M Seed

Blank Bio Raises $7.2M Seed

Blank Bio, a San Francisco, CA-based AI startup focused on developing RNA foundation models for precision medicine, has raised $7.2 million in seed financing.

Define Ventures, Leonis Capital, Nova Threshold, Ripple Ventures, SignalFire, and Y Combinator.

Blank Bio plans to use the capital to double down on model development, generate additional training data, and expand collaborations with pharmaceutical and diagnostic companies.

Founded in 2025 by Jonathan Hsu, Philip Fradkin, and Ian Shi, Blank Bio is an AI technology company dedicated to creating RNA foundation models. The company aims to leverage bulk RNA sequencing data to provide clinical insights for oncology and other disease indications, with a goal of enabling end-to-end transcriptomic analysis for pharmaceutical and diagnostic applications.

Funding Details

Company: Blank Bio

Raised: $7.2M

Round: Seed

Funding Date: May 19, 2026

Additional Investors: Define Ventures, Leonis Capital, Nova Threshold, Ripple Ventures, SignalFire, Y Combinator

Software Category: Healthcare AI

Company Website: https://blank.bio